HC Wainwright reissued their buy rating on shares of Omega Therapeutics (NASDAQ:OMGA – Get Rating) in a research report sent to investors on Friday, Benzinga reports. They currently have a $11.00 target price on the stock. Several other equities research analysts also recently issued reports on OMGA. Jonestrading began coverage on shares of Omega Therapeutics […]
Omega Therapeutics (NASDAQ:OMGA – Get Rating) and Miromatrix Medical (NASDAQ:MIRO – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends and institutional ownership. Valuation & Earnings This table compares Omega Therapeutics and […]
A number of firms have modified their ratings and price targets on shares of Omega Therapeutics (NASDAQ: OMGA) recently: 5/24/2022 – Omega Therapeutics had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $7.00 to $4.00. They now have a “neutral” rating on the stock. 5/24/2022 – Omega Therapeutics was downgraded […]
Omega Therapeutics (NASDAQ:OMGA – Get Rating) is one of 259 public companies in the “Biological products, except diagnostic” industry, but how does it contrast to its rivals? We will compare Omega Therapeutics to related companies based on the strength of its dividends, valuation, earnings, profitability, risk, institutional ownership and analyst recommendations. Institutional and Insider Ownership […]